Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19897418 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  InductionChemo-Radio-Antibody-Treatment
Conditions: Squamous Cell Carcinoma of the Head;   Squamous Cell Carcinoma of the Neck
Interventions: Drug: TPF induction chemotherapy;   Drug: TPF experimental;   Radiation: Standard Radiochemotherapy (HART)
2 Terminated Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Procedure: conventional surgery;   Radiation: radiation therapy
3 Not yet recruiting Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP
4 Recruiting The Quarterback Trial
Condition: Squamous Cell Carcinomas
Interventions: Radiation: Reduced Dose Radiation;   Radiation: Standard Dose Radiation

Indicates status has not been verified in more than two years